Outset Medical Inc Receivables Turnover Ratio (OM), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Outset Medical Inc   (NASDAQ: OM)
 

Outset Medical Inc Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Outset Medical Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 3.84, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the first quarter 2026. Average receivable collection period, for the Outset Medical Inc in Mar 31 2026 quarter, has decreased to 95 days, compared to 102 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 318 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 681 to 2209.

What is Receivable Turnover Ratio?
What is Outset Medical Inc Selling?


What is Receivable Turnover Ratio?





OM Receivables Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Receivable Change -31.36 % -20.47 % -3.79 % 2.26 % 1.13 %
Y / Y Revenue Change -6.78 % -4.78 % 2.77 % 15.25 % 6.8 %
Receivable Turnover Ratio (TTM) 3.84 3.57 3.43 3.37 3.28
OM's Total Ranking # 2209 # 681 # 2120 # 1741 # 1832
Accounts Receivable average collection period days 95 102 106 108 111
Seq. Receivable Change -10.61 % -14.06 % -5.53 % -5.42 % 3.57 %
Seq. Revenue Change -10.37 % 5.74 % -7.38 % 6.2 % -8.44 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 319
Overall Market # 2209

Receivable Turnover Ratio Statistics
High Average Low
0.43 0.32 0.12
(Mar 31 2026)   (Dec 31 2020)






Financial Statements
Outset Medical Inc 's Accounts Receivable $ 25 Millions Visit OM's Balance sheet
Outset Medical Inc 's Sales TTM $ 117 Millions Visit OM's Income Statement
Sources of OM's Revenues Visit OM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OM's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OM's Growth Rates OM's Roa OM's Inventory Turnover Ratio OM's Dividend Comparisons
OM's Profitability Ratios OM's Roi OM's Asset Turnover Ratio OM's Dividend Growth
OM's Valuation Ratios OM's Roe OM's Financial Strength Ratios OM's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026
Lftd Partners Inc   12.55 $ 36.955  Millions$ 2.945  Millions
Clene Inc   12.47 $ 0.134  Millions$ 0.011  Millions
Skinhealth Systems Inc   12.27 $ 295.223  Millions$ 24.052  Millions
Cytokinetics Incorporated  12.16 $ 105.815  Millions$ 8.702  Millions
Precision Biosciences Inc  11.94 $ 45.073  Millions$ 3.776  Millions
Teladoc Health Inc   11.94 $ 2,514.453  Millions$ 210.660  Millions
Option Care Health Inc   11.65 $ 5,666.577  Millions$ 486.439  Millions
Ensysce Biosciences Inc   11.55 $ 4.708  Millions$ 0.407  Millions
Crinetics Pharmaceuticals Inc   11.52 $ 18.069  Millions$ 1.569  Millions
Icu Medical Inc  11.46 $ 2,156.379  Millions$ 188.157  Millions
Nrc Health  11.42 $ 138.642  Millions$ 12.138  Millions
Nuvation Bio Inc   11.41 $ 142.121  Millions$ 12.454  Millions
Integrated Biopharma Inc  11.34 $ 47.241  Millions$ 4.165  Millions
National Healthcare Corp  11.07 $ 1,525.905  Millions$ 137.813  Millions
Vireo Growth Inc.  11.01 $ 350.469  Millions$ 31.834  Millions
Bioaffinity Technologies Inc   10.79 $ 5.660  Millions$ 0.525  Millions
Vivos Therapeutics Inc   10.73 $ 19.092  Millions$ 1.779  Millions
Veracyte Inc   10.68 $ 516.183  Millions$ 48.353  Millions
Immucell Corporation  10.51 $ 29.035  Millions$ 2.762  Millions
Kestra Medical Technologies Ltd   10.51 $ 93.819  Millions$ 8.925  Millions
Lifeloc Technologies Inc   10.41 $ 9.044  Millions$ 0.869  Millions
Monte Rosa Therapeutics Inc   10.39 $ 42.953  Millions$ 4.136  Millions
International Stem Cell Corporation  10.23 $ 9.286  Millions$ 0.908  Millions
Pavmed Inc   10.19 $ 0.107  Millions$ 0.011  Millions
Viemed Healthcare Inc   10.16 $ 286.565  Millions$ 28.217  Millions
Addus Homecare Corp  10.14 $ 1,447.070  Millions$ 142.667  Millions
Utah Medical Products Inc  10.13 $ 36.745  Millions$ 3.629  Millions
Petvivo Holdings Inc   10.10 $ 0.821  Millions$ 0.081  Millions
Irhythm Holdings Inc   10.00 $ 787.387  Millions$ 78.720  Millions
C4 Therapeutics Inc   9.97 $ 34.861  Millions$ 3.496  Millions

Date modified: 2026-08-29T17:42:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.